Mark Coleman

Director at Axsome Therapeutics · 14 reported transactions in 1 company · latest trade Jun 10, 2026

Their record

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +28.7%, S&P 500 +5.8% over the same days.

Jun 10, 2026 · AXSM

$160.1K

S&P 500 +5.5%thru Oct 26

Jun 2, 2026 · AXSM

$1.24M

S&P 500 +0.8%thru Oct 26

Jun 1, 2026 · AXSM

$1.38M

S&P 500 +0.9%thru Oct 26

May 29, 2026 · AXSM

$1.4M

S&P 500 +1.2%thru Oct 26

Feb 26, 2026 · AXSM

$4.03M

S&P 500 +11.0%thru Oct 26

Sep 8, 2025 · AXSM

$62.2K

S&P 500 +18.0%thru Oct 26

Newest 10 of 14 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Axsome Therapeutics · 14 reported transactions in 1 company · latest trade Jun 10, 2026

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +28.7%, S&P 500 +5.8% over the same days.